Literature DB >> 17431895

Smith-Magenis syndrome and Moyamoya disease in a patient with del(17)(p11.2p13.1).

Santhosh Girirajan1, Roberto Mendoza-Londono, Christopher N Vlangos, Lucie Dupuis, Norma J Nowak, David J Bunyan, Eli Hatchwell, Sarah H Elsea.   

Abstract

Chromosomal rearrangements causing microdeletions and microduplications are a major cause of congenital malformation and mental retardation. Because they are not visible by routine chromosome analysis, high resolution whole-genome technologies are required for the detection and diagnosis of small chromosomal abnormalities. Recently, array-comparative genomic hybridization (aCGH) and multiplex ligation-dependent probe amplification (MLPA) have been useful tools for the identification and mapping of deletions and duplications at higher resolution and throughput. Smith-Magenis syndrome (SMS) is a multiple congenital anomalies/mental retardation syndrome caused by deletion or mutation of the retinoic acid induced 1 (RAI1) gene and is often associated with a chromosome 17p11.2 deletion. We report here on the clinical and molecular analysis of a 10-year-old girl with SMS and moyamoya disease (occlusion of the circle of Willis). We have employed a combination of aCGH, FISH, and MLPA to characterize an approximately 6.3 Mb deletion spanning chromosome region 17p11.2-p13.1 in this patient, with the proximal breakpoint within the RAI1 gene. Further, investigation of the genomic architecture at the breakpoint intervals of this large deletion documented the presence of palindromic repeat elements that could potentially form recombination substrates leading to unequal crossover.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17431895     DOI: 10.1002/ajmg.a.31689

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  6 in total

Review 1.  Juvenile Moyamoya and Craniosynostosis in a Child with Deletion 1p32p31: Expanding the Clinical Spectrum of 1p32p31 Deletion Syndrome and a Review of the Literature.

Authors:  Paolo Prontera; Daniela Rogaia; Amedea Mencarelli; Valentina Ottaviani; Ester Sallicandro; Giorgio Guercini; Susanna Esposito; Anna Bersano; Giuseppe Merla; Gabriela Stangoni
Journal:  Int J Mol Sci       Date:  2017-09-17       Impact factor: 5.923

2.  Distinctive facial features in idiopathic Moyamoya disease in Caucasians: a first systematic analysis.

Authors:  Markus Kraemer; Quoc Bao Huynh; Dagmar Wieczorek; Brunilda Balliu; Barbara Mikat; Stefan Boehringer
Journal:  PeerJ       Date:  2018-06-27       Impact factor: 2.984

3.  Microduplication of 15q13.3 and Microdeletion of 18q21.32 in a Patient with Moyamoya Syndrome.

Authors:  Sciacca Francesca Luisa; Ambra Rizzo; Gloria Bedini; Fioravante Capone; Vincenzo Di Lazzaro; Sara Nava; Francesco Acerbi; Davide Sebastiano Rossi; Simona Binelli; Giuseppe Faragò; Andrea Gioppo; Marina Grisoli; Maria Grazia Bruzzone; Paolo Ferroli; Chiara Pantaleoni; Luigi Caputi; Jesus Vela Gomez; Eugenio Agostino Parati; Anna Bersano
Journal:  Int J Mol Sci       Date:  2018-11-20       Impact factor: 5.923

Review 4.  Smith-Magenis Syndrome-Clinical Review, Biological Background and Related Disorders.

Authors:  Berardo Rinaldi; Roberta Villa; Alessandra Sironi; Livia Garavelli; Palma Finelli; Maria Francesca Bedeschi
Journal:  Genes (Basel)       Date:  2022-02-11       Impact factor: 4.096

5.  Behavioral disturbance and treatment strategies in Smith-Magenis syndrome.

Authors:  Alice Poisson; Alain Nicolas; Pierre Cochat; Damien Sanlaville; Caroline Rigard; Hélène de Leersnyder; Patricia Franco; Vincent Des Portes; Patrick Edery; Caroline Demily
Journal:  Orphanet J Rare Dis       Date:  2015-09-04       Impact factor: 4.123

6.  Detection of Partial Deletions of Y-chromosome AZFc in Infertile Men Using the Multiplex Ligation-dependent Probe Amplification Assay.

Authors:  David J Bunyan; Jonathan L A Callaway; Nadja Laddach
Journal:  J Reprod Infertil       Date:  2012-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.